Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 140Head and Neck Neoplasms 114Carcinoma, Non-Small-Cell Lung 49Thyroid Neoplasms 42Melanoma 36Nasopharyngeal Carcinoma 35Mouth Neoplasms 35Ovarian Neoplasms 30Breast Neoplasms 30Oropharyngeal Neoplasms 29Colorectal Neoplasms 29Neoplasm Metastasis 26Uterine Cervical Neoplasms 24Lung Neoplasms 22Neoplasms 20Carcinoma, Squamous Cell 20Carcinoma, Renal Cell 20Carcinoma 19Stomach Neoplasms 18Pancreatic Neoplasms 17Prostatic Neoplasms 16Esophageal Neoplasms 16Endometrial Neoplasms 16Triple Negative Breast Neoplasms 15Laryngeal Neoplasms 15Sarcoma 14Urinary Bladder Neoplasms 13Hypopharyngeal Neoplasms 12Carcinoma, Transitional Cell 12Salivary Gland Neoplasms 11

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 2 × Head & Neck × 30 days × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡